Grifols SA GRFS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 12/09/22 EST
7.86UNCH (UNCH)
Volume
472
Close
7.86quote price arrow up+0.09 (+1.16%)
Volume
1,041,692
52 week range
5.71 - 13.34
Loading...
  • Open7.94
  • Day High7.95
  • Day Low7.78
  • Prev Close7.77
  • 52 Week High13.34
  • 52 Week High Date05/24/22
  • 52 Week Low5.71
  • 52 Week Low Date10/21/22

Key Stats

  • Market Cap5.404B
  • Shares Out687.55M
  • 10 Day Average Volume0.77M
  • Dividend0.66
  • Dividend Yield8.37%
  • Beta0.49
  • YTD % Change-30.01

KEY STATS

  • Open7.94
  • Day High7.95
  • Day Low7.78
  • Prev Close7.77
  • 52 Week High13.34
  • 52 Week High Date05/24/22
  • 52 Week Low5.71
  • 52 Week Low Date10/21/22
  • Market Cap5.404B
  • Shares Out687.55M
  • 10 Day Average Volume0.77M
  • Dividend0.66
  • Dividend Yield8.37%
  • Beta0.49
  • YTD % Change-30.01

RATIOS/PROFITABILITY

  • EPS (TTM)0.36
  • P/E (TTM)21.69
  • Fwd P/E (NTM)-
  • EBITDA (TTM)1.131B
  • ROE (TTM)1.14%
  • Revenue (TTM)5.496B
  • Gross Margin (TTM)36.90%
  • Net Margin (TTM)2.68%
  • Debt To Equity (MRQ)156.20%

EVENTS

  • Earnings Date-
  • Ex Div Date06/03/2021
  • Div Amount0.4566
  • Split Date-
  • Split Factor-

Latest On Grifols SA

Content From Our Affiliates

Profile

MORE
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing...
Steven Mayer J.D.
Executive Chairman of the Board of Directors
Victor Grifols Roura
Honorary Chairman of the Board, Proprietary Director
Alfredo Arroyo Guerra
Chief Financial Officer
Address
C/ Jesus y Maria, 6
Barcelona, BAR
08022
Spain